CStone Pharmaceuticals

HKSE:02616 (China)  
HK$ 2.34 (0%) Dec 24
At Loss
P/B:
5.92
Market Cap:
HK$ 3.01B ($ 384.20M)
Enterprise V:
HK$ 2.50B ($ 318.48M)
Volume:
2.17M
Avg Vol (2M):
2.94M
Trade In:
Volume:
2.17M
At Loss
Avg Vol (2M):
2.94M

Business Description

Description
CStone Pharmaceuticals is engaged in the development and commercialization of tumor immunotherapy and molecular-targeted drugs. It has been operating in one reportable segment, the research and development of complex biopharmaceutical products.
Name Current Vs Industry Vs History
Cash-To-Debt 2.43
Equity-to-Asset 0.31
Debt-to-Equity 0.72
Debt-to-EBITDA -2.57
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -6.32
Distress
Grey
Safe
Beneish M-Score -1.61
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 38.85
9-Day RSI 48.39
14-Day RSI 53.17
6-1 Month Momentum % 83.18
12-1 Month Momentum % -9.68

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.71
Quick Ratio 1.45
Cash Ratio 1.14
Days Inventory 396.43
Days Sales Outstanding 140.63
Days Payable 748.58

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -2.8
Shareholder Yield % -1.99

Financials (Next Earnings Date:2025-03-27 Est.)

HKSE:02616's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

CStone Pharmaceuticals Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil HK$) 494.966
EPS (TTM) (HK$) -0.12
Beta 0.89
Volatility % 73.83
14-Day RSI 53.17
14-Day ATR (HK$) 0.146629
20-Day SMA (HK$) 2.342
12-1 Month Momentum % -9.68
52-Week Range (HK$) 0.8 - 2.78
Shares Outstanding (Mil) 1,275.32

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

CStone Pharmaceuticals Filings

Filing Date Document Date Form
No Filing Data

CStone Pharmaceuticals Stock Events

Financials Calendars
Event Date Price(HK$)
No Event Data

CStone Pharmaceuticals Frequently Asked Questions

What is CStone Pharmaceuticals(HKSE:02616)'s stock price today?
The current price of HKSE:02616 is HK$2.34. The 52 week high of HKSE:02616 is HK$2.78 and 52 week low is HK$0.80.
When is next earnings date of CStone Pharmaceuticals(HKSE:02616)?
The next earnings date of CStone Pharmaceuticals(HKSE:02616) is 2025-03-27 Est..
Does CStone Pharmaceuticals(HKSE:02616) pay dividends? If so, how much?
CStone Pharmaceuticals(HKSE:02616) does not pay dividend.

Press Release

Subject Date
No Press Release